Figure 1.

Management of advanced HFrEF patients. ACEi, angiotensin‐converting enzyme inhibitors; ARNI, angiotensin receptor neprilysin inhibitor; CRT, cardiac resynchronization therapy; FCM, ferric carboxymaltose; GDMT, guideline‐directed medical therapy; HFrEF, heart failure with reduced ejection fraction; HTx, heart transplantation; ICD, implantable cardioverter defibrillator; LVAD, left ventricular assist device; MRA, mineralocorticoid receptor antagonists; SGLT2, sodium‐glucose co‐transporter 2.